We are open with limited hours and staff.
Price range: $189.00 through $807.00
Hydrocodone 7.5mg/650mg is a historical prescription combination containing 7.5mg of hydrocodone bitartrate and 650mg of acetaminophen per tablet. Hydrocodone is an opioid analgesic, while acetaminophen provides non-opioid pain-relieving and fever-reducing effects. Older DailyMed labeling documents this strength as an oral tablet formulation.
Because this formulation contains a relatively high amount of acetaminophen per tablet, its safety profile deserves particular attention. In addition, hydrocodone carries important opioid-related risks, including sedation, respiratory depression, misuse, dependence, and overdose.
This medication combines two active ingredients that work differently. Hydrocodone acts on opioid receptors within the central nervous system and changes how the body perceives pain. Acetaminophen works through a different analgesic pathway and can provide additional pain relief.
Therefore, the combination requires careful consideration of both ingredients. A healthcare professional should evaluate the patient’s medical history, other medications, previous opioid exposure, and individual risk factors before prescribing an appropriate treatment.
Historically, hydrocodone and acetaminophen tablets were prescribed for the management of pain when an opioid analgesic was considered appropriate. Older labeling specifically documented the 7.5mg/650mg strength and provided dosing information for adult patients.
However, historical product information should not be interpreted as confirmation that this exact strength remains marketed or approved in every jurisdiction. Patients should verify the current product information supplied by their healthcare professional or regulatory authority.
Hydrocodone can cause significant central nervous system effects, including drowsiness, impaired alertness, and respiratory depression. Moreover, opioid medicines carry risks of misuse, abuse, addiction, overdose, and potentially fatal breathing problems.
Acetaminophen presents a separate safety concern. Excessive exposure can cause severe liver injury, particularly when a person takes multiple acetaminophen-containing products. Older labeling specifically warned about hepatotoxicity and noted that serious liver injury can occur when daily acetaminophen exposure becomes excessive.
For this reason, patients should tell their healthcare professional about every prescription medicine, over-the-counter product, supplement, and alcoholic beverage they use.
Potential effects associated with this combination may include:
Additionally, excessive acetaminophen exposure may result in serious liver injury. Warning signs of severe toxicity require prompt medical attention.
Patients should seek emergency assistance for severe breathing difficulty, extreme sedation, loss of consciousness, or suspected opioid overdose.
Hydrocodone-containing medication should only be used under appropriate medical supervision. Patients should follow the instructions provided for their specific prescription and should never share opioid medication with another person.
Likewise, patients should avoid taking additional acetaminophen-containing medicines without first discussing the total amount with a healthcare professional. This precaution is particularly important with the historical 650mg acetaminophen formulation.
Alcohol and other substances that cause sedation can increase the risks associated with opioid treatment. Consequently, patients should discuss these substances with their healthcare provider before using an opioid-containing medicine.
The 7.5mg/650mg strength is documented in older U.S. drug labeling, including DailyMed records identifying each tablet as containing 7.5mg hydrocodone bitartrate and 650mg acetaminophen.
Current product availability and approved strengths can differ from historical labeling. Therefore, consumers should verify the exact product name, active ingredients, strength, manufacturer, and regulatory status rather than relying on an older product description.
Acetaminophen appears in many prescription and nonprescription medicines. As a result, taking multiple products containing the ingredient can unintentionally increase total daily exposure.
Patients with liver disease, significant alcohol use, or other relevant risk factors should discuss acetaminophen exposure with a qualified healthcare professional. Never assume that combining several pain medicines is safe simply because they have different brand names.
Hydrocodone 7.5mg/650mg combines an opioid analgesic with acetaminophen and therefore requires careful attention to both opioid-related and liver-related safety risks. The exact 7.5mg/650mg formulation is documented in historical DailyMed labeling, but current availability and regulatory status should be verified for the relevant jurisdiction.
